Form 4: Annovis Bio Director Reid McCarthy Boosts Stake with Common Stock Purchase
Insider Transaction Report
Annovis Bio, Inc. Director Reid McCarthy acquired 2,000 shares of common stock at $2.95 per share, increasing his beneficial ownership to 9,305 shares.
Summary
- Reid McCarthy, a Director of Annovis Bio, Inc. (ANVS), acquired 2,000 shares of the company's common stock.
- The transaction occurred on June 10, 2025, at a price of $2.95 per share.
- Following this acquisition, Mr. McCarthy's direct beneficial ownership in Annovis Bio, Inc. increased to 9,305 shares.
Sentiment
Score: 7
Explanation: The acquisition of common stock by a director is generally viewed as a positive signal, indicating confidence from an insider with intimate knowledge of the company's operations and prospects.
Positives
- The acquisition of 2,000 shares by Director Reid McCarthy indicates confidence in Annovis Bio, Inc.'s future prospects at the current share price.
- This insider buying activity further aligns the director's personal financial interests with those of the company's shareholders.
Future Outlook
This Form 4 filing reports a past transaction and does not contain forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This filing is a standard disclosure of an insider transaction and does not provide broader industry context or trends. It reflects an individual director's investment decision within the biotechnology sector.
Related Party Transactions
- The acquisition of 2,000 shares of common stock by Reid McCarthy, a Director of Annovis Bio, Inc., constitutes a related party transaction.
Stakeholder Impact
- Shareholders: May interpret the insider purchase as a positive indicator of management's confidence, potentially bolstering investor sentiment.
- Management/Board: Reinforces alignment between the director's personal investment and the company's performance and strategic direction.
Key Dates
| Date | Description |
|---|---|
| 06/10/2025 | Date of common stock acquisition by Director Reid McCarthy. |
| 06/11/2025 | Date the Form 4 filing was signed by the attorney-in-fact for the reporting person. |
Keywords
Annovis Bio, ANVS, Form 4, insider trading, stock purchase, director, beneficial ownership, common stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.